Loading live market data…

International Flavors & Fragrances Inc.

NYSE:IFF

$74.67 USD

-$0.43 (-0.57%)

Volume
1.9M
Average Volume
1.99M
Market Capitalization
$19.06B
P/E Ratio
22.77
Dividend Yield
2.14%
Price Target
$90.00
Year High
$84.45
Year Low
$59.14
Day High
Day Low
Payout Ratio
$0.48
Current Ratio
$1.49
Source Headline
IFF to Release Second Quarter 2026 Results on August 4, 2026

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) today announced that it will release its second quarter 2026 earnings results following the market close on Tuesday, August 4, 2026. The management team will host a live webcast on Wednesday, August 5, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded.

businesswire.com - 2026-07-09 16:15:00

IFF Advances Pro-Fragrance Innovation With SENSORA Launch

International Flavors launches patent-pending SENSORA, a pro-fragrance technology that extends scent for up to 20 days and debuts with Floral Fusion detergents.

zacks.com - 2026-07-02 12:40:17

IFF Launches SENSORA™, an Innovative Pro-Fragrance Technology Platform

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health and biosciences — today announced the launch of SENSORA™, its advanced patent-pending pro-fragrance technology designed to transform how scent is experienced across home, fabric and personal care applications. Developed to meet the rising demand for a longer-lasting and more sophisticated scent experience, SENSORA™ delivers an evolving olfactive profile with sustained release, extend.

businesswire.com - 2026-06-30 08:00:00

IFF and ISIPCA Mark 10 Years of Joint Scent Design and Creation Master's-Level Program

[url="]IFF[/url] — a global leader in flavors, fragrances, food ingredients and health and biosciences — celebrates the 10th anniversary of its industry-lead

gurufocus.com - 2026-06-16 12:00:00

IFF and ISIPCA Mark 10 Years of Joint Scent Design and Creation Master's-Level Program

VERSAILLES, France--(BUSINESS WIRE)--IFF — a global leader in flavors, fragrances, food ingredients and health & biosciences — celebrates the 10th anniversary of its industry-leading accredited master's-level program for scent design and creation, developed in partnership with ISIPCA, the world-renowned school for careers in perfume, cosmetics and food flavors. Since its launch in 2016, the IFF ISIPCA program has trained more than 180 professionals from 40 countries, with 130 graduates to d.

businesswire.com - 2026-06-16 11:00:00

IFF's 2025 Do More Good Report Highlights Progress in Nature-Based Innovation

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health & biosciences — released its 2025 Do More Good Report, highlighting the company's commitment to creating better products and experiences for people and the planet. IFF's increasingly nature-based portfolio underscores the central role of sustainability and positions its innovation at the intersection of biology and chemistry. Through continued investment in R&D, expanded glob.

businesswire.com - 2026-06-09 07:00:00

International Flavors (IFF) Down 11.3% Since Last Earnings Report: Can It Rebound?

International Flavors (IFF) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-04 12:36:33

IFF to Optimize Portfolio With Its Food Ingredients Business Sale

International Flavors sells its Food Ingredients unit as part of a portfolio overhaul, aiming to cut debt and focus on higher-growth, innovation-led segments.

zacks.com - 2026-06-01 11:25:30

IFF Reshapes Portfolio With $4.3 Billion Sale, Targets Higher-Margin Business

International Flavors & Fragrances Inc. (NYSE:IFF) shares are slightly down on Friday. The company is advancing its portfolio transformation with the sale of its Food Ingredients business to CVC for about $4.3 billion.

benzinga.com - 2026-05-29 13:50:07

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to

gurufocus.com - 2026-05-29 07:00:00

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to.

businesswire.com - 2026-05-29 06:50:00

Flavor Maker IFF Nears $4 Billion Deal to Sell Food Ingredients Business to CVC

A sale of IFF's largest division would be the company's latest move to boost profitability.

wsj.com - 2026-05-29 04:53:00

LMR by IFF Inaugurates New Experimental Field in Grasse

[url="]LMR Naturals by IFF[/url]—a global leader in natural ingredients for perfumery, cosmetics and flavors—today inaugurated its new experimental field,

gurufocus.com - 2026-05-28 06:00:00

LMR by IFF Inaugurates New Experimental Field in Grasse

GRASSE, France--(BUSINESS WIRE)--LMR Naturals by IFF—a global leader in natural ingredients for perfumery, cosmetics and flavors—today inaugurated its new experimental field, Domaine des Naturels LMR. The field is dedicated to advancing research in natural ingredients, preserving Grasse's agricultural heritage and expanding education in naturals. The inauguration, attended by Grasse Mayor Jérôme Viaud, a long-standing supporter of the perfume industry, underscores IFF and LMR's ongoing commitme.

businesswire.com - 2026-05-28 05:00:00

Reasons Why You Should Retain IFF Stock in Your Portfolio Now

International Flavors eyes long-term growth through portfolio streamlining, emerging market demand and disciplined capital allocation strategies.

zacks.com - 2026-05-25 11:26:04

Unlocking International Flavors (IFF) International Revenues: Trends, Surprises, and Prospects

Explore how International Flavors' (IFF) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

zacks.com - 2026-05-11 10:16:31

IFF Opens Vanilla Innovation Center in Madagascar

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health & bioscience—today announced the opening of its Vanilla Innovation Center in Madagascar, reinforcing vanilla as a strategic and priority tonality for IFF and strengthening its ability to innovate at origin. “The opening of the center marks an important step in how we approach vanilla innovation,” said Adam Jańczuk, Ph.D., senior vice president, research, creation and design, Taste, IF.

businesswire.com - 2026-05-11 08:15:00

International Flavors & Fragrances Q1 Earnings Call Highlights

International Flavors & Fragrances NYSE: IFF reported a stronger-than-expected start to 2026, with first-quarter sales growth across all business segments, higher adjusted profitability and improved free cash flow, while management reaffirmed its full-year guidance despite macroeconomic uncertainty tied in part to the Middle East conflict.

marketbeat.com - 2026-05-10 20:05:32

LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery

GRASSE, France--(BUSINESS WIRE)--LMR Naturals by IFF — a global leader in natural ingredients for perfumery, cosmetics and flavors — will debut its latest innovations at the International Exhibition of Raw Materials for Perfumery (SIMPPAR), May 26–27 in Grasse. During the industry event, IFF will unveil new additions to its LMR Hearts collection, highlighting its naturals expertise and pioneering science. “Responsible innovation has always been central to LMR,” said Bertrand de Préville, genera.

businesswire.com - 2026-05-07 03:00:00

International Flavors & Fragrances Inc. (IFF) Q1 2026 Earnings Call Transcript

International Flavors & Fragrances Inc. (IFF) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-06 12:21:17

IFF Q1 Earnings Beat Estimates on Volume Growth & Productivity Gains

International Flavors beats Q1 estimates on volume growth and productivity gains, boosting margins and cash flow while reaffirming 2026 outlook despite a softer sales decline.

zacks.com - 2026-05-06 09:11:05

International Flavors (IFF) Q1 Earnings and Revenues Beat Estimates

International Flavors (IFF) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.2 per share a year ago.

zacks.com - 2026-05-05 19:05:29

Compared to Estimates, International Flavors (IFF) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for International Flavors (IFF) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com - 2026-05-05 19:00:52

International Flavors & Fragrances beats quarterly sales and profit estimates

Food ingredients maker International Flavors & Fragrances beat Wall Street expectations for first-quarter sales and profit on ​Tuesday, helped by steady demand for its products.

reuters.com - 2026-05-05 17:18:47

IFF Reports First Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.7 B   $209 M   $0.66   $568 M   20.7%   $1.25 Management Commentary “IFF is off to a solid start in 2026, with first quarter results that reflect the customer focus and operational execution we've been.

businesswire.com - 2026-05-05 16:15:00

International Flavors Gears Up to Report Q1 Earnings: What's in Store?

IFF heads into Q1 results with sales and profit seen declining, even as volume growth and segment gains aim to offset rising input and operating costs.

zacks.com - 2026-05-01 13:16:08

IFF Declares Dividend for Second Quarter 2026

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 10, 2026 to shareholders of record as of June 18, 2026. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—adva.

businesswire.com - 2026-04-29 16:25:00

International Flavors (IFF) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

International Flavors (IFF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-28 11:00:54

Get IFF Insider Trade Alerts

IFF Price Target Summary

Last Month

$95.00

1 analysts

Last Quarter

$91.67

3 analysts

Last Year

$85.11

19 analysts

All Time

$100.48

46 analysts

IFF Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-01 Morgan Stanley Maintain Overweight Overweight
2026-06-30 Argus Research Maintain Buy Buy
2026-06-24 Citigroup Maintain Buy Buy
2026-05-08 Barclays Maintain Overweight Overweight
2026-05-07 JP Morgan Maintain Overweight Overweight
2026-05-07 Oppenheimer Maintain Outperform Outperform
2026-05-07 Citigroup Maintain Buy Buy
2026-04-22 Oppenheimer Maintain Outperform Outperform
2026-04-14 Barclays Maintain Overweight Overweight
2026-04-13 Citigroup Maintain Buy Buy
2026-04-09 UBS Maintain Neutral Neutral
2026-02-17 Barclays Maintain Overweight Overweight
2026-02-17 Mizuho Maintain Outperform Outperform
2026-02-13 Wells Fargo Maintain Overweight Overweight
2026-02-13 Oppenheimer Upgrade Perform Outperform
2026-02-13 Citigroup Maintain Buy Buy
2026-02-12 Mizuho Maintain Outperform Outperform
2026-01-22 Argus Research Maintain Buy Buy
2026-01-21 Citigroup Maintain Buy Buy
2026-01-12 UBS Maintain Neutral Neutral
2025-11-07 Barclays Maintain Overweight Overweight
2025-11-06 UBS Maintain Neutral Neutral
2025-10-14 B of A Securities Maintain Buy Buy
2025-10-07 Argus Research Maintain Buy Buy
2025-10-06 UBS Maintain Neutral Neutral
2025-10-06 Citigroup Maintain Buy Buy
2025-10-03 Mizuho Maintain Outperform Outperform
2025-09-22 Morgan Stanley Maintain Overweight Overweight
2025-09-08 Wolfe Research Upgrade Underperform Peer Perform
2025-08-26 Tigress Financial Maintain Buy Buy
2025-08-08 Barclays Maintain Overweight Overweight
2025-08-07 Wells Fargo Maintain Overweight Overweight
2025-08-06 UBS Maintain Neutral Neutral
2025-05-13 Morgan Stanley Maintain Overweight Overweight
2025-05-08 Citigroup Maintain Buy Buy
2025-05-08 Baird Maintain Outperform Outperform
2025-05-08 Barclays Upgrade Equal Weight Overweight
2025-05-07 UBS Maintain Neutral Neutral
2025-04-22 Oppenheimer Maintain Outperform Outperform
2025-04-15 Mizuho Maintain Outperform Outperform
2025-04-14 Barclays Maintain Equal Weight Equal Weight
2025-04-10 Morgan Stanley Maintain Overweight Overweight
2025-04-10 Stifel Maintain Buy Buy
2025-04-09 Wells Fargo Maintain Overweight Overweight
2025-04-08 Citigroup Maintain Buy Buy
2025-03-27 Barclays Maintain Equal Weight Equal Weight
2025-02-20 Wells Fargo Maintain Overweight Overweight
2025-02-20 Oppenheimer Maintain Outperform Outperform
2025-02-20 B of A Securities Maintain Buy Buy
2025-02-20 JP Morgan Maintain Overweight Overweight
2025-02-03 Stifel Maintain Buy Buy
2025-01-28 Oppenheimer Maintain Outperform Outperform
2025-01-17 Barclays Maintain Equal Weight Equal Weight
2025-01-07 Argus Research Upgrade Hold Buy
2024-12-18 Citigroup Maintain Buy Buy
2024-11-12 Morgan Stanley Upgrade Equal Weight Overweight
2024-11-07 JP Morgan Maintain Overweight Overweight
2024-11-07 Vertical Research Upgrade Hold Buy
2024-11-06 UBS Maintain Neutral Neutral
2024-10-24 Stifel Maintain Buy Buy
2024-10-11 Barclays Maintain Equal Weight Equal Weight
2024-09-11 Oppenheimer Maintain Outperform Outperform
2024-09-06 JP Morgan Maintain Overweight Overweight
2024-09-03 Mizuho Upgrade Neutral Outperform
2024-08-15 UBS Maintain Neutral Neutral
2024-08-08 JP Morgan Maintain Overweight Overweight
2024-08-08 Wells Fargo Maintain Overweight Overweight
2024-08-07 UBS Maintain Neutral Neutral
2024-07-22 Stifel Upgrade Hold Buy
2024-07-12 Citigroup Maintain Buy Buy
2024-07-09 UBS Maintain Neutral Neutral
2024-07-03 Morgan Stanley Maintain Equal Weight Equal Weight
2024-05-21 Morgan Stanley Downgrade Overweight Equal Weight
2024-05-10 B of A Securities Maintain Neutral Neutral
2024-05-08 Citigroup Maintain Buy Buy
2024-05-08 Baird Maintain Outperform Outperform
2024-05-08 Barclays Maintain Equal Weight Equal Weight
2024-05-08 JP Morgan Upgrade Neutral Overweight
2024-05-08 Wells Fargo Maintain Overweight Overweight
2024-05-07 Stifel Maintain Hold Hold
2024-05-07 Mizuho Maintain Neutral Neutral
2024-04-12 Barclays Maintain Underweight Underweight
2024-04-10 Citigroup Upgrade Neutral Buy
2024-04-04 Wells Fargo Maintain Overweight Overweight
2024-03-27 Morgan Stanley Maintain Overweight Overweight
2024-03-20 Mizuho Maintain Neutral Neutral
2024-03-20 Deutsche Bank Maintain Buy Buy
2024-03-08 Argus Research Downgrade Buy Hold
2024-02-26 Mizuho Maintain Neutral Neutral
2024-02-23 Citigroup Maintain Neutral Neutral
2024-02-22 Baird Maintain Outperform Outperform
2024-02-22 Wells Fargo Maintain Overweight Overweight
2024-02-21 Mizuho Maintain Neutral Neutral
2024-02-21 Stifel Maintain Hold Hold
2024-01-22 Morgan Stanley Upgrade Equal Weight Overweight
2024-01-12 Barclays Maintain Underweight Underweight
2024-01-12 Jefferies Upgrade Hold Buy
2024-01-11 UBS Maintain Neutral Neutral
2023-12-20 Stifel Maintain Hold Hold
2023-12-06 Morgan Stanley Maintain Equal Weight Equal Weight
2023-11-28 Argus Research Upgrade Hold Buy
2023-11-13 UBS Downgrade Buy Neutral
2023-11-08 Wells Fargo Maintain Overweight Overweight
2023-11-07 Stifel Maintain Hold Hold
2023-10-12 Barclays Maintain Underweight Underweight
2023-09-14 Stifel Maintain Hold Hold
2023-08-24 Morgan Stanley Downgrade Overweight Equal Weight
2023-08-10 Barclays Maintain Underweight Underweight
2023-08-10 Goldman Sachs Maintain Neutral Neutral
2023-08-09 Wells Fargo Maintain Overweight Overweight
2023-08-09 JP Morgan Maintain Neutral Neutral
2023-08-09 Goldman Sachs Downgrade Buy Neutral
2023-08-09 Deutsche Bank Maintain Buy Buy
2023-08-09 Citigroup Maintain Neutral Neutral
2023-08-08 Credit Suisse Maintain Outperform Outperform
2023-08-08 Stifel Downgrade Buy Hold
2023-07-18 Wells Fargo Maintain Overweight Overweight
2023-07-18 Goldman Sachs Maintain Buy Buy
2023-07-03 Morgan Stanley Maintain Overweight Overweight
2023-06-30 Morgan Stanley Maintain Overweight Overweight
2023-05-26 JP Morgan Maintain Neutral Neutral
2023-05-18 Morgan Stanley Maintain Overweight Overweight
2023-05-11 Barclays Maintain Underweight Underweight
2023-05-09 UBS Maintain Buy Buy
2023-04-05 Morgan Stanley Maintain Overweight Overweight
2023-03-29 Barclays Maintain Underweight Underweight
2023-03-20 UBS Maintain Buy Buy
2023-02-13 Barclays Maintain Underweight Underweight
2023-02-10 Mizuho Maintain Neutral Neutral
2023-02-10 Wells Fargo Maintain Overweight Overweight
2023-02-10 Credit Suisse Maintain Outperform Outperform
2023-02-10 Baird Maintain Outperform Outperform
2023-02-10 Deutsche Bank Maintain Buy Buy
2023-02-09 UBS Maintain Buy Buy
2023-02-09 Credit Suisse Maintain Outperform Outperform
2023-01-25 Goldman Sachs Maintain Buy Buy
2023-01-12 Mizuho Maintain Neutral Neutral
2023-01-11 B of A Securities Downgrade Buy Underperform
2023-01-11 UBS Maintain Buy Buy
2022-12-15 UBS Maintain Buy Buy
2022-12-12 Barclays Maintain Underweight Underweight
2022-12-08 Wells Fargo Maintain Overweight Overweight
2022-11-09 Baird Maintain Outperform Outperform
2022-11-09 Wells Fargo Maintain Overweight Overweight
2022-11-09 Credit Suisse Maintain Outperform Outperform
2022-11-09 Mizuho Maintain Neutral Neutral
2022-11-09 JP Morgan Downgrade Overweight Neutral
2022-11-09 Societe Generale Maintain Buy Buy
2022-11-08 Credit Suisse Maintain Outperform Outperform
2022-10-18 Goldman Sachs Maintain Buy Buy
2022-10-18 Wells Fargo Maintain Overweight Overweight
2022-10-17 Deutsche Bank Maintain Buy Buy
2022-09-26 Morgan Stanley Maintain Overweight Overweight
2022-08-24 Berenberg Downgrade Buy Hold
2022-08-11 Barclays Maintain Underweight Underweight
2022-08-11 Morgan Stanley Maintain Overweight Overweight
2022-08-10 Wells Fargo Maintain Overweight Overweight
2022-07-13 B of A Securities Maintain Buy Buy
2022-06-27 Credit Suisse Maintain Outperform Outperform
2022-06-16 Jefferies Downgrade Buy Hold
2022-05-12 Deutsche Bank Maintain Buy Buy
2022-05-11 Mizuho Maintain Neutral Neutral
2022-05-11 Wells Fargo Maintain Overweight Overweight
2022-04-18 Wells Fargo Maintain Overweight Overweight
2022-03-24 Berenberg Downgrade Buy Hold
2022-02-14 Wells Fargo Maintain Overweight Overweight
2022-02-14 Barclays Maintain Underweight Underweight
2022-01-26 Stifel Upgrade Hold Buy
2022-01-13 Jefferies Maintain Buy Buy
2022-01-04 UBS Maintain Buy Buy
2021-12-13 Wells Fargo Maintain Overweight Overweight
2021-11-12 Deutsche Bank Maintain Buy Buy
2021-11-10 Wells Fargo Maintain Overweight Overweight
2021-11-10 Mizuho Maintain Neutral Neutral
2021-10-13 Mizuho Maintain Neutral Neutral
2021-08-09 Wells Fargo Maintain Overweight Overweight
2021-06-28 Wells Fargo Maintain Overweight Overweight
2021-05-13 Jefferies Maintain Buy Buy
2021-05-12 Wells Fargo Maintain Overweight Overweight
2021-03-25 Berenberg Upgrade Hold Buy
2021-03-11 Jefferies Maintain Buy Buy
2021-02-12 JP Morgan Maintain Overweight Overweight
2021-01-12 Societe Generale Upgrade Hold Buy
2021-01-12 Exane BNP Paribas Upgrade Underperform Neutral
2020-11-12 Societe Generale Upgrade Sell Hold
2020-08-26 Baird Maintain Outperform Outperform
2020-08-12 Stifel Maintain Hold Hold
2020-07-10 Stephens & Co. Maintain Overweight Overweight
2020-06-22 Exane BNP Paribas Downgrade Neutral Underperform
2020-05-13 CFRA Maintain Buy Buy
2020-05-13 Citigroup Maintain Neutral Neutral
2020-05-12 UBS Maintain Buy Buy
2020-04-29 Wells Fargo Upgrade Equal Weight Overweight
2020-04-09 Citigroup Maintain Neutral Neutral
2020-04-08 UBS Maintain Buy Buy
2020-04-06 Exane BNP Paribas Upgrade Underperform Neutral
2020-02-14 Wells Fargo Maintain Equal Weight Equal Weight
2019-12-17 Deutsche Bank Maintain Buy Buy
2019-12-16 Stifel Nicolaus Maintain Hold Hold
2019-12-12 Deutsche Bank Maintain Buy Buy
2019-12-06 JP Morgan Maintain Overweight Overweight
2019-11-22 Citi Upgrade Neutral Buy
2019-11-06 Wells Fargo Maintain Market Perform Perform
2019-11-06 Citigroup Maintain Neutral Neutral
2019-10-16 Wells Fargo Maintain Market Perform Perform
2019-10-09 Citigroup Maintain Neutral Neutral
2019-10-02 UBS Maintain Buy Buy
2019-09-10 Societe Generale Maintain Buy Buy
2019-08-08 Berenberg Downgrade Buy Hold
2019-08-08 KeyBanc Maintain Overweight Overweight
2019-08-07 JP Morgan Upgrade Neutral Overweight
2019-06-07 KeyBanc Maintain Overweight Overweight
2019-05-07 UBS Maintain Buy Buy
2019-03-21 Goldman Sachs Upgrade Neutral Buy
2019-02-25 KeyBanc Maintain Overweight Overweight
2019-02-21 Citigroup Maintain Neutral Neutral
2018-11-16 Raymond James Downgrade Market Perform Underperform
2018-11-16 Citigroup Maintain Neutral Neutral
2018-10-16 Deutsche Bank Upgrade Hold Buy
2018-08-09 Stifel Nicolaus Maintain Hold Hold
2018-06-11 Stifel Nicolaus Maintain Hold Hold
2018-06-08 Argus Downgrade Buy Hold
2018-05-08 Stifel Nicolaus Maintain Hold Hold
2018-05-08 Deutsche Bank Maintain Hold Hold
2018-05-08 JP Morgan Upgrade Underweight Neutral
2018-03-16 JP Morgan Downgrade Neutral Underweight
2018-02-16 KeyBanc Maintain Overweight Overweight
2018-02-15 Deutsche Bank Maintain Hold Hold
2018-01-17 Evercore ISI Group Upgrade In Line Outperform
2017-11-08 KeyBanc Maintain Overweight Overweight
2017-11-07 UBS Maintain Buy Buy
2017-10-16 KeyBanc Maintain Overweight Overweight
2017-08-10 Deutsche Bank Maintain Hold Hold
2017-07-07 Raymond James Maintain Market Perform Perform
2017-02-23 UBS Upgrade Neutral Buy
2017-02-14 Evercore ISI Group Maintain Hold Hold
2017-01-09 Barclays Downgrade Equal Weight Underweight
2017-01-06 Exane BNP Paribas Downgrade Outperform Neutral
2016-11-21 Goldman Sachs Maintain Neutral Neutral
2016-08-16 Argus Maintain Buy Buy
2016-08-10 Gabelli & Co. Downgrade Buy Hold
2016-08-09 UBS Maintain Neutral Neutral
2016-07-20 Berenberg Maintain Buy Buy
2016-07-20 Deutsche Bank Maintain Hold Hold
2016-03-14 KeyBanc Maintain Overweight Overweight
2016-02-11 Deutsche Bank Downgrade Buy Hold
2016-02-11 UBS Maintain Neutral Neutral
2016-01-25 Stifel Nicolaus Downgrade Buy Hold
2015-10-01 Edward Jones Maintain Buy Buy
2015-09-15 Deutsche Bank Maintain Buy Buy
2015-08-21 Morgan Stanley Upgrade Equal Weight Overweight
2015-08-11 UBS Maintain Neutral Neutral
2015-06-03 Stifel Nicolaus Maintain Buy Buy
2015-05-19 Exane BNP Paribas Maintain Outperform Outperform
2015-05-13 Stifel Nicolaus Maintain Buy Buy
2015-04-09 Edward Jones Maintain Hold Hold
2015-03-23 Stifel Nicolaus Maintain Buy Buy
2015-02-26 Stifel Nicolaus Maintain Buy Buy
2015-02-13 Stifel Nicolaus Maintain Buy Buy
2015-02-13 JP Morgan Maintain Neutral Neutral
2015-02-13 Deutsche Bank Maintain Buy Buy
2014-08-13 Argus Maintain Buy Buy
2014-08-06 JP Morgan Maintain Neutral Neutral
2014-07-16 KeyBanc Maintain Buy Buy
2014-06-20 UBS Maintain Neutral Neutral
2014-05-09 JP Morgan Maintain Neutral Neutral
2014-05-07 Deutsche Bank Maintain Buy Buy
2014-05-07 Stifel Nicolaus Maintain Buy Buy
2014-02-14 Stifel Nicolaus Maintain Buy Buy
2013-12-03 Morgan Stanley Downgrade Overweight Equal Weight
2013-11-25 Janney Capital Maintain Buy Buy
2013-07-01 KeyBanc Upgrade Hold Buy
2013-05-20 Stifel Nicolaus Maintain Buy Buy
2013-05-08 Stifel Nicolaus Maintain Buy Buy
2013-05-07 Morgan Stanley Maintain Overweight Overweight
2013-03-21 Argus Upgrade Hold Buy
2013-02-08 Stifel Nicolaus Maintain Buy Buy
2012-08-09 JP Morgan Downgrade Overweight Neutral